Skip to content

Ascenta Capital

Organization · Investor

Minutes holds 1 deal naming Ascenta Capital.

Deals in Minutes

Deals naming Ascenta Capital
CompanyDealAmountCounterpartiesDate ↓Status
Iambic TherapeuticsBiotechFundingSeries B$100MLed by Ascenta Capital, AbingworthWith NVIDIA, Illumina Ventures +93 Oct 2023Closed
Showing 1–1 of 1

Investments

1 deal Minutes has recorded · 1 led
Rounds recorded
1
Since 2023
Led
1
100% of its rounds
Companies recorded
1
Exits recorded
1
1 IPO

By stage

Rounds recorded since 2023

  • Series B1

By industry

Rounds recorded since 2023; a round in two industries counts in each

  • Healthcare1
  • Technology1

By region

Rounds recorded since 2023, by the company's headquarters region

  • Region not recorded1

Deals Minutes has recorded

Rounds naming this investor that Minutes has recorded
DateCompanyRoundAmountRoleOutcome
3 October 2023Iambic Therapeutics HealthcareSeries B$100MLedListed · Oct 2026

1 of 1

Exits

Each exit, with the rounds Ascenta Capital joined before it

Iambic Therapeutics · Listed · 14 October 2026

Ascenta Capital joined: Series B (led)

Returns not shown: Minutes does not hold stake sizes unless a party discloses them.

Co-investors in these rounds

Abingworth1 round togetherOct 03, 2023
NVIDIA1 round togetherOct 03, 2023
Illumina Ventures1 round togetherOct 03, 2023
Gradiant Corporation1 round togetherOct 03, 2023
Shanda1 round togetherOct 03, 2023
Nexus Venture Partners1 round togetherOct 03, 2023
Catalio Capital Management1 round togetherOct 03, 2023
Coatue1 round togetherOct 03, 2023

4 more in Minutes

Ascenta Capital

No developments name Ascenta Capital yet.